MYND Life Sciences Inc. (MYND.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.8 Million CAD | 40.99% |
| 2022 | -3.06 Million CAD | 28.62% |
| 2021 | -4.29 Million CAD | -7500.29% |
| 2020 | -56.46 Thousand CAD | -2127.46% |
| 2019 | -2535.00 CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -221.23 Thousand CAD | 33.85% |
| 2024 Q1 | -334.43 Thousand CAD | 14.66% |
| 2024 Q3 | -341.77 Thousand CAD | -54.49% |
| 2023 Q4 | -391.89 Thousand CAD | -24.64% |
| 2023 Q2 | -436.83 Thousand CAD | 32.34% |
| 2023 Q1 | -645.59 Thousand CAD | -4.41% |
| 2023 FY | -1.83 Million CAD | 40.19% |
| 2023 Q3 | -314.42 Thousand CAD | 28.02% |
| 2022 Q3 | -682.74 Thousand CAD | 4.8% |
| 2022 Q2 | -717.18 Thousand CAD | 37.87% |
| 2022 Q1 | -1.15 Million CAD | 19.65% |
| 2022 FY | -3.06 Million CAD | 28.62% |
| 2022 Q4 | -618.35 Thousand CAD | 9.43% |
| 2021 Q3 | -853.33 Thousand CAD | -11.92% |
| 2021 FY | -4.29 Million CAD | -7500.29% |
| 2021 Q2 | -762.42 Thousand CAD | 35.39% |
| 2021 Q4 | -1.43 Million CAD | -68.34% |
| 2021 Q1 | -1.18 Million CAD | 0.0% |
| 2020 FY | -56.46 Thousand CAD | -2127.46% |
| 2019 FY | -2535.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -5.01 Million CAD | 63.975% |
| Asep Medical Holdings Inc | -7.72 Million CAD | 76.587% |
| BetterLife Pharma Inc. | -3.24 Million CAD | 44.209% |
| BioVaxys Technology Corp. | -2.4 Million CAD | 24.758% |
| ChitogenX Inc. | -2.83 Million CAD | 36.121% |
| Rapid Dose Therapeutics Corp. | -3.73 Million CAD | 51.648% |
| Defence Therapeutics Inc. | -12.65 Million CAD | 85.716% |
| Entheon Biomedical Corp. | -313.99 Thousand CAD | -475.74% |
| Gemina Laboratories Ltd. | -5.08 Million CAD | 64.455% |
| Glow Lifetech Corp. | -1.64 Million CAD | -10.048% |
| Lexston Life Sciences Corp. | -674.71 Thousand CAD | -167.931% |
| Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | -136.946% |
| Doseology Sciences Inc. | -377.63 Thousand CAD | -378.713% |
| Nova Mentis Life Science Corp. | -1.2 Million CAD | -50.36% |
| PharmaTher Holdings Ltd. | -3.04 Million CAD | 40.613% |
| PreveCeutical Medical Inc. | -963.12 Thousand CAD | -87.699% |
| Telescope Innovations Corp. | -5.76 Million CAD | 68.652% |